Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant
The Japanese heavyweight Ono Pharmaceutical has recruited Numab Therapeutics for a second time to co-develop…
31/03/2020 - 3 minutes
The Japanese heavyweight Ono Pharmaceutical has recruited Numab Therapeutics for a second time to co-develop…
Numab and Intarcia have a first candidate to combine a tri-specific antibody fragment with a…
Ono Pharmaceutical is offering the Swiss Numab €241M (CHF 258M) for the development of a…
The biggest city in Switzerland, Zurich, is one of Europe's top financial centers and home…
Numab and Intarcia have achieved key milestones in the development of therapeutic antibody fragments. This…